Mani, Inc. (7730.T) stock price, financials & research

Regular session · JST · Market data may be delayed.

Company profile

Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.

Industry: Medical - Instruments & Supplies
Sector: Healthcare
Headquarters: JP
CEO: Masaya Watanabe
Listed since: Feb 22, 2010
Employees: 4,140

Market position

Day range

Current ¥1,618

¥1,602¥1,628

52-week range

Current ¥1,618

¥1,236.5¥1,955

Open: ¥1,602
Previous close: ¥1,603
Volume: 245.7K; 0.69× average
Average volume: 355.61K; Average daily volume
Market cap: 159.38B JPY
Beta: 0.38; Market reference 1
50-day average: ¥1,634.84; -1.03% below average
200-day average: ¥1,589.2; +1.81% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 105.22B JPY
P/E (TTM): 23.59×
P/B (TTM): 2.78×
P/S (TTM): 4.98×
EV / EBITDA: 11.01×
Earnings yield: 3.76%
Free cash flow yield: 0.50%
Dividend yield: 2.47%

Profitability & efficiency

Gross margin: 66.28%
Operating margin: 29.70%
Net margin: 21.13%
Return on equity: 8.67%
Return on assets: 7.98%
Return on invested capital: 9.81%

Financial health

Debt / equity: 0×
Current ratio: 8.58×
Altman Z-score: 20.87
Piotroski F-score: 6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

29.97B JPY+5.10%

Operating income

8.19B JPY-2.37%

Net income

4.64B JPY-26.14%

Metric (JPY)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	29.97B JPY	28.51B JPY	24.49B JPY	20.42B JPY	17.19B JPY
Cost of goods sold	10.65B JPY	10.62B JPY	9.07B JPY	7.84B JPY	6.19B JPY
Gross profit	19.32B JPY	17.9B JPY	15.42B JPY	12.58B JPY	11.01B JPY
Research and development	—	—	2.19B JPY	1.56B JPY	1.5B JPY
Selling, general, and administrative	11.12B JPY	6.74B JPY	5.65B JPY	4.53B JPY	3.89B JPY
Operating expenses	11.13B JPY	9.51B JPY	8.18B JPY	6.41B JPY	5.66B JPY
Interest income	240M JPY	206M JPY	194M JPY	112M JPY	74M JPY
Interest expense	3M JPY	6M JPY	2M JPY	2M JPY	1M JPY
Depreciation and amortization	2.47B JPY	2.27B JPY	1.92B JPY	1.75B JPY	1.54B JPY
Operating income	8.19B JPY	8.39B JPY	7.24B JPY	6.16B JPY	5.35B JPY
Net income	4.64B JPY	6.29B JPY	5.95B JPY	5.29B JPY	4.29B JPY